CAS 1110813-31-4 appears in our catalog under these names: (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide, 99%, 99%, Dacomitinib, Dacomitinib, >95% (HPLC), Dacomitinib/ 100%, Dacomitinib (PF299804, PF299). Offered by: Chemat, Chemat Brand, TRC, TargetMol, GLPBio. Available pack sizes: 5mg, 10mg, 100mg, 250mg, 1g, 5g, 10g, on request.
Dacomitinib is a member of the class of quinazolines that is 7-methoxyquinazoline-4,6-diamine in which the amino group at position 4 is substituted by a 3-chloro-4-fluorophenyl group and the amino group at position 6 is substituted by an (E)-4-(piperidin-1-yl)but-2-enoyl group. It has a role as an antineoplastic agent and an epidermal growth factor receptor antagonist. It is a secondary carboxamide, a member of piperidines, a member of quinazolines, a secondary amino compound, a tertiary amino compound, an enamide, a member of monochlorobenzenes and a member of monofluorobenzenes.
Source: ChEBI
| Molecular formula | C24H25ClFN5O2 |
|---|---|
| Molecular weight | 469.9 g/mol |
| IUPAC name | (E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide |
| InChIKey | LVXJQMNHJWSHET-AATRIKPKSA-N |
| SMILES | COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4CCCCC4 |
Computed by PubChem (NCBI)